Titan Medical Inc (TMDIF)

[saveferris]

The talk needs to shift back to whether or not mgmt. is getting milestones completed on time. There's a lot of focus on PPS, but the fact of the matter is this is an R&D stock. Shareholder value relies on the commercialization of a product, and unlike a mine or a semiconductor, the loops to jump through in biotech are speculative and unpredictable. The big loops haven't been completed yet, and that's why investors are holding off on buying.

As for mgmt. and their shares, it is quite possible that they already know they have a suitor but no one will pull the trigger until certain regulatory thresholds have been met. So who cares about shareholder value as long as the device is completed--that's an attitude they may have. It is all speculation. Focus on what we do know, not what we suspect. The cards will be turned over in time. Get excited about the conferences, devices, and in-human trials. That is the story of 2016, a much better narrative than 2015.